SCHEMBL31269115

SCHEMBL31269115

Cc1ccnc(Cn2c(-c3ccc(C(=O)N(C)CCO)cc3Cl)nc3c(OC4(C)CC4)ncnc32)c1

nearest known ligand 0.34

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ PIK3CD O00329 2/20 0.34
▸ SMO Q99835 1/20 0.32
▸ CYP11B2 P19099 1/20 0.32
▸ USP1 O94782 2/20 0.31
▸ PDK2 Q15119 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31269314 0.92 PIK3CD (0.33) PIK3CD
SCHEMBL31269182 0.92 PIK3CD (0.36) PIK3CD
SCHEMBL31269002 0.91 PIK3CD (0.34) PIK3CD
SCHEMBL31269080 0.89 PIK3CD (0.33) PIK3CD
SCHEMBL31269275 0.88 KDM4E (0.35) PIK3CDPDK2
SCHEMBL31269475 0.88 PIK3CD (0.37) PIK3CD
SCHEMBL31269136 0.87 PIK3CD (0.36) PIK3CD
SCHEMBL31268949 0.87 PIK3CD (0.35) PIK3CD
SCHEMBL31268737 0.87 PIK3CD (0.35) PIK3CDUSP1
SCHEMBL31269478 0.86 SYK (0.36) PIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4689155-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS Astrazeneca AB (SE) 2026-02-11 — — EP disclosed
WO-2024201368-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS ASTRAZENECA AB (SE) 2024-10-03 — — WO disclosed
Send feedback